XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Interim Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Income Statement [Abstract]        
Research and development expenses, net $ 747 $ 377 $ 1,130 $ 561
General and administrative expenses 1,145 885 2,277 1,934
Operating loss (1,892) (1,262) (3,407) (2,495)
Financing income (expenses), net (1) (2,246) 45 (2,320)
Net loss $ (1,893) $ (3,508) $ (3,362) $ (4,815)
Net loss per share, basic and diluted $ (0.04) $ (0.09) $ (0.08) $ (0.13)
Weighted-average number of common shares outstanding, basic and diluted 42,831,416 29,108,410 42,146,315 28,165,518